From: Risk factors for surgery-related muscle quantity and muscle quality loss and their impact on outcome
 | Total n = 128 (100%) | Muscle quantity loss n = 67 (52%) | No muscle quantity loss n = 61 (48%) | P-value | Muscle quality loss n = 83 (65%) | No muscle quality loss n = 45 (35%) | P-value |
---|---|---|---|---|---|---|---|
Complicated postoperative course | 52 (40.6%) | 25 (37.3%) | 27 (44.3%) | 0.424 | 39 (47%) | 13 (28,9%) | 0.047 |
Cardiopulmonary | 23 (18.0%) | 10 (14.9%) | 13 (21.3%) | 0.347 | 17 (20.5%) | 6 (13.3%) | 0.315 |
Incisional SSI | 8 (6.3%) | 5 (7.5%) | 3 (4.9%) | 0.552 | 6 (7.2%) | 2 (4.4%) | 0.534 |
Intra-abdominal SSI | 10 (7.8%) | 5 (7.5%) | 5 (8.2%) | 0.877 | 8 (9.6%) | 2 (4.4%) | 0.296 |
Infectious, other | 6 (4.7%) | 5 (7.5%) | 1 (1.6%) | 0.120 | 1 (1.2%) | 1 (2.2%) | 0.658 |
Bacteraemia | 2 (1.6%) | 2 (3.0%) | 0 (0.0%) | 0.174 | 6 (7.2%) | 0 (0.0%) | 0.065 |
Bile leak (≥ ISGLS Grade B) | 5 (3.9%) | 1 (1.5%) | 4 (6.6%) | 0.140 | 3 (3.6%) | 2 (4.4%) | 0.817 |
DGE (grade A, B or C) | 5 (3.9%) | 2 (3.0%) | 3 (4.9%) | 0.573 | 4 (4.8%) | 1 (2.2%) | 0.469 |
Thromboembolic event | 3 (2.3%) | 1 (1.5%) | 2 (3.3%) | 0.505 | 2 (2.4%) | 1 (2.2%) | 0.947 |
Bleeding | 1 (0.8%) | 1 (1.5%) | 0 (0.0%) | 0.338 | 1 (1.2%) | 0 (0.0%) | 0.460 |
Single organ failure | 3 (2.3%) | 1 (1.5%) | 2 (3.3%) | 0.505 | 2 (2.4%) | 1 (2.2%) | 0.947 |
Other | 11 (8.6%) | 5 (7.5%) | 6 (9.8%) | 0.632 | 9 (10.8%) | 2 (4.4%) | 0.217 |
Clavien–Dindo ≥ 3 | 18 (14.1%) | 9 (13.4%) | 9 (14.8%) | 0.830 | 13 (15.7%) | 5 (11.1%) | 0.479 |
Length of hospital stay, mean (SD) | 9.7 (5.3) | 9.4 (4.5) | 10.0 (6.2) | 0.522 | 10.3 (4.3) | 8.6 (6.8) | 0.084 |